In a meta-analysis of 10 studies, including 3159 patients, HSF1 protein abundance was also associated with shorter overall survival in esophageal squamous cell carcinoma, breast cancer, HCC, as well as non-small cell lung cancer (NSCLC) and pancreatic cancer (167). This evidence concerns the gene HSF1 and breast cancer.